LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | PI103 | 10 | uM | LJP6 | 2 | I13 | 72 | hr | 962 | 1020 | 10740 | 0.0950 | 0.0169 |
MCF 10A | PI103 | 10 | uM | LJP6 | 3 | I13 | 72 | hr | 962 | 1195 | 10641 | 0.1123 | 0.0645 |
MCF 10A | Dovitinib | 0.04 | uM | LJP5 | 1 | E24 | 72 | hr | 962 | 10639 | 10714 | 0.9930 | 0.9960 |
MCF 10A | Dovitinib | 0.04 | uM | LJP5 | 2 | E24 | 72 | hr | 962 | 10934 | 10507 | 1.0406 | 1.0232 |
MCF 10A | Dovitinib | 0.04 | uM | LJP5 | 3 | E24 | 72 | hr | 962 | 9878 | 10315 | 0.9576 | 0.9749 |
MCF 10A | Dovitinib | 0.12 | uM | LJP5 | 1 | E23 | 72 | hr | 962 | 9359 | 10714 | 0.8735 | 0.9237 |
MCF 10A | Dovitinib | 0.12 | uM | LJP5 | 2 | E23 | 72 | hr | 962 | 9658 | 10507 | 0.9191 | 0.9517 |
MCF 10A | Dovitinib | 0.12 | uM | LJP5 | 3 | E23 | 72 | hr | 962 | 9263 | 10315 | 0.8980 | 0.9381 |
MCF 10A | Dovitinib | 0.37 | uM | LJP5 | 1 | E22 | 72 | hr | 962 | 3581 | 10714 | 0.3342 | 0.4593 |
MCF 10A | Dovitinib | 0.37 | uM | LJP5 | 2 | E22 | 72 | hr | 962 | 3526 | 10507 | 0.3356 | 0.4573 |
MCF 10A | Dovitinib | 0.37 | uM | LJP5 | 3 | E22 | 72 | hr | 962 | 4623 | 10315 | 0.4482 | 0.5819 |
MCF 10A | Dovitinib | 1.11 | uM | LJP5 | 1 | E21 | 72 | hr | 962 | 1588 | 10714 | 0.1482 | 0.1550 |
MCF 10A | Dovitinib | 1.11 | uM | LJP5 | 2 | E21 | 72 | hr | 962 | 1815 | 10507 | 0.1727 | 0.2020 |
MCF 10A | Dovitinib | 1.11 | uM | LJP5 | 3 | E21 | 72 | hr | 962 | 1626 | 10315 | 0.1576 | 0.1657 |
MCF 10A | Dovitinib | 3.33 | uM | LJP5 | 1 | E20 | 72 | hr | 962 | 1150 | 10714 | 0.1073 | 0.0526 |
MCF 10A | Dovitinib | 3.33 | uM | LJP5 | 2 | E20 | 72 | hr | 962 | 1099 | 10507 | 0.1046 | 0.0393 |
MCF 10A | Dovitinib | 3.33 | uM | LJP5 | 3 | E20 | 72 | hr | 962 | 1175 | 10315 | 0.1139 | 0.0601 |
MCF 10A | Dovitinib | 10 | uM | LJP5 | 1 | E19 | 72 | hr | 962 | 963 | 10714 | 0.0899 | 0.0003 |
MCF 10A | Dovitinib | 10 | uM | LJP5 | 2 | E19 | 72 | hr | 962 | 950 | 10507 | 0.0904 | -0.0037 |
MCF 10A | Dovitinib | 10 | uM | LJP5 | 3 | E19 | 72 | hr | 962 | 852 | 10315 | 0.0826 | -0.0349 |
MCF 10A | GSK 690693 | 0.04 | uM | LJP5 | 1 | F24 | 72 | hr | 962 | 10632 | 10714 | 0.9924 | 0.9956 |
MCF 10A | GSK 690693 | 0.04 | uM | LJP5 | 2 | F24 | 72 | hr | 962 | 10534 | 10507 | 1.0025 | 1.0014 |
MCF 10A | GSK 690693 | 0.04 | uM | LJP5 | 3 | F24 | 72 | hr | 962 | 10281 | 10315 | 0.9967 | 0.9981 |
MCF 10A | GSK 690693 | 0.12 | uM | LJP5 | 1 | F23 | 72 | hr | 962 | 9559 | 10714 | 0.8922 | 0.9355 |
MCF 10A | GSK 690693 | 0.12 | uM | LJP5 | 2 | F23 | 72 | hr | 962 | 10207 | 10507 | 0.9714 | 0.9832 |